BlackRock’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.72M | Sell |
2,566,524
-2,312,309
| -47% | -$3.35M | ﹤0.01% | 3815 |
|
|
2025
Q1 | $6.73M | Sell |
4,878,833
-82,867
| -2% | -$114K | ﹤0.01% | 3468 |
|
|
2024
Q4 | $15.1M | Buy |
4,961,700
+328,824
| +7% | +$1,000K | ﹤0.01% | 3168 |
|
|
2024
Q3 | $23.1M | Buy |
4,632,876
+170,524
| +4% | +$849K | ﹤0.01% | 2900 |
|
|
2024
Q2 | $26.1M | Buy |
4,462,352
+2,763,139
| +163% | +$16.2M | ﹤0.01% | 2778 |
|
|
2024
Q1 | $13.5M | Buy |
1,699,213
+27,486
| +2% | +$218K | ﹤0.01% | 3139 |
|
|
2023
Q4 | $9.75M | Sell |
1,671,727
-8,722
| -0.5% | -$50.8K | ﹤0.01% | 3339 |
|
|
2023
Q3 | $4.3M | Buy |
1,680,449
+416,996
| +33% | +$1.07M | ﹤0.01% | 3652 |
|
|
2023
Q2 | $3.16M | Sell |
1,263,453
-251,597
| -17% | -$629K | ﹤0.01% | 3800 |
|
|
2023
Q1 | $3.18M | Buy |
1,515,050
+1,104
| +0.1% | +$2.32K | ﹤0.01% | 3757 |
|
|
2022
Q4 | $2.35M | Buy |
1,513,946
+131
| +0% | +$203 | ﹤0.01% | 3992 |
|
|
2022
Q3 | $4.62M | Sell |
1,513,815
-1,149
| -0.1% | -$3.5K | ﹤0.01% | 3715 |
|
|
2022
Q2 | $4.77M | Sell |
1,514,964
-4,224
| -0.3% | -$13.3K | ﹤0.01% | 3759 |
|
|
2022
Q1 | $4.25M | Buy |
1,519,188
+20,650
| +1% | +$57.8K | ﹤0.01% | 3974 |
|
|
2021
Q4 | $6.74M | Sell |
1,498,538
-2,039
| -0.1% | -$9.18K | ﹤0.01% | 3809 |
|
|
2021
Q3 | $12.5M | Buy |
+1,500,577
| New | +$12.5M | ﹤0.01% | 3520 |
|